Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- Added a government funding/operating status notice and current NIH Clinical Center information; updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference1%
- Check24 days agoChange DetectedContent update: terminology refined from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a new version tag v3.1.0.SummaryDifference0.1%
- Check38 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated to include a new facility name and location, as well as specific resources related to clear cell renal carcinoma and kidney cancer. Additionally, several medical terms and proteins have been added, while some previous terms and locations have been removed.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.